PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Standardized aqueous root extract resulted in a dose-dependent reduction in serum creatinine, β2-microglobulin, and blood urea nitrogen in Wistar rats [PMID:34396545]
Ethanolic extract of intact and spent roots and hexane fractions showed potent antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv and H(37)Ra strains in vitro [PMID:23131375]
Preclinical studies demonstrate efficacy in mitigating inflammation, alleviating pain, and exhibiting antidiabetic effects [PMID:41008619]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 34215988 (2021) — Chrysopogon zizanioides-a review on its pharmacognosy, chemical composition and pharmacological activities. · Environmental science and pollution research international
- 2.PMID: 19810597 (2009) — Vetiver grass, Vetiveria zizanioides: a choice plant for phytoremediation of heavy metals and organic wastes. · International journal of phytoremediation
- 3.PMID: 29408073 (2018) — Agronomic and economic evaluation of Vetiver grass (Vetiveria zizanioides L.) as means for phytoremediation of diesel polluted soils in Israel. · Journal of environmental management
- 4.PMID: 40431000 (2025) — Vetiver, Vetiveria zizanioides (L.) Nash: Biotechnology, Biorefineries, and the Production of Volatile Phytochemicals. · Plants (Basel, Switzerland)
- 5.PMID: 31176744